Oncology
Dose optimisation in oncology: Insights from AACR 2026 and i...
Five years after its launch, the FDA’s Project Optimus remained a key theme in discussions at AACR 2026.
News
Manufacturing hangover drives Daiichi Sankyo into the red
Long-term third-party manufacturing contracts and a slower-than-expected rollout of its cancer ADCs have driven Daiichi Sankyo into a net loss.
News
CellCentric pockets $220m for blood cancer programme
CellCentric has raised $220 million in a Series D financing that will help fund pivotal trials of p300/CBP inhibitor inobrodib in multiple myeloma.
News
BioNTech winds down COVID jab manufacturing, shedding staff
BioNTech's plan to shed 22% of its workforce and stop COVID-19 vaccine production has earned it a rebuke from Germany's third-largest labour union.
News
UK's Cytospire draws in $83m for new T-cell engager platform
Cytospire was in the spotlight this morning after announcing an oversubscribed Series A to fund a new form of T-cell engager (TCE) for cancer.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
